You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 3, 2026
A Label-free Technique for the Spatio-temporal Imaging of Single Cell Secretions
Published on: November 23, 2015
Jinling Zhang1, Yi Wang, Ten It Wong
1Centre for Biomimetic Sensor Science, School of Materials Science and Engineering, Nanyang Technological University, 50 Nanyang Drive, Singapore 637553. bliedberg@ntu.edu.sg yiwang@ntu.edu.sg.
This study introduces a new sensor design that uses electrical charges to improve the detection of heart-related proteins in complex biological samples, overcoming common limitations like slow molecule movement and unwanted background signals.
11:44Surface Enhanced Raman Spectroscopy Detection of Biomolecules Using EBL Fabricated Nanostructured Substrates
Published on: March 20, 2015
10:43Author Spotlight: Single-Molecule Surface-Enhanced Raman Scattering Measurements Enabled by Plasmonic DNA Origami Nanoantennas
Published on: July 21, 2023
Area of Science:
Background:
Current diagnostic platforms often struggle with slow analyte delivery to sensing surfaces. This diffusion-limited transport hinders the rapid detection of biomarkers in clinical settings. Furthermore, background signals from unwanted molecules frequently obscure target identification. No prior work had resolved these challenges simultaneously within a single device architecture. Researchers have long sought methods to improve sensitivity in complex biological fluids. That uncertainty drove the development of active transport mechanisms for biosensing. Prior research has shown that surface modifications can mitigate some interference issues. This gap motivated the exploration of integrated electrical and optical sensing modalities.
Purpose Of The Study:
The study aims to enhance the sensitivity of localized surface plasmon resonance biosensors. Researchers address the persistent challenge of diffusion-limited mass transport in clinical diagnostics. They seek to mitigate the negative impact of nonspecific adsorption in complex biofluids. The team investigates the utility of peptide-modified gold nanohole arrays for this purpose. This work explores the application of a negative electric bias to concentrate target molecules. The primary motivation is to improve the detection of human troponin I. This goal drives the development of an active transport sensing platform. The researchers intend to demonstrate a robust solution for real-time biomarker analysis.
Main Methods:
The investigation utilizes a peptide-functionalized gold nanohole array architecture. Review approach framing involves evaluating the integration of electrophoretic control with optical detection. Investigators apply a controlled negative potential to the sensing substrate. This setup enables the active manipulation of charged biomolecules near the interface. The team monitors real-time binding events through changes in resonance frequency. They compare performance metrics against standard passive diffusion conditions. The experimental protocol focuses on the detection of cardiac troponin I. This methodology ensures precise control over the local chemical environment during analysis.
Main Results:
Key findings from the literature indicate that the negative bias significantly accelerates target accumulation. The active transport mechanism overcomes the inherent slowness of passive diffusion in complex samples. Data show that the platform successfully detects human troponin I in real-time. The electrical field simultaneously reduces the interference caused by non-target protein adsorption. This dual-action approach improves the overall sensitivity of the gold nanohole array. The results confirm that the bias effectively concentrates the analyte at the sensor surface. The study provides evidence that this integration minimizes background noise. These observations highlight the efficacy of combining electrical and optical sensing techniques.
Conclusions:
The authors demonstrate that applying a negative bias improves target capture efficiency. This approach effectively concentrates cardiac troponin I at the sensor interface. The electrical field simultaneously reduces binding of non-target proteins. These findings suggest that active transport enhances overall device sensitivity. The study confirms that gold nanohole arrays provide a robust platform for such integration. Synthesis and implications indicate that this method addresses mass transport limitations. The team proposes that this strategy improves performance in complex biofluids. Future applications may benefit from this combined electrical and optical detection framework.
The researchers propose that a negative electric bias attracts positively charged troponin I to the gold surface. This active concentration mechanism overcomes diffusion limitations, while the field simultaneously repels other proteins to minimize nonspecific adsorption, thereby improving signal-to-noise ratios compared to passive sensing methods.
The device utilizes a peptide-modified gold nanohole array. This specific surface functionalization is necessary to facilitate the capture of the target protein while maintaining the optical properties required for localized surface plasmon resonance detection, distinguishing it from standard planar electrode configurations.
A negative electric bias is necessary to create an electrophoretic force. This force drives the target molecules toward the sensor, a requirement for overcoming the slow arrival of analytes typically seen in diffusion-limited environments, unlike passive systems that rely solely on Brownian motion.
The researchers employ human troponin I as the model analyte. This protein serves as a clinical biomarker, and its detection in real biofluids is often compromised by the presence of interfering substances, necessitating the active transport approach described in the study.
The study measures real-time binding kinetics using localized surface plasmon resonance. This optical phenomenon allows for the continuous monitoring of molecular interactions at the interface, providing a dynamic readout of the concentration process, which is distinct from endpoint-based diagnostic assays.
The authors suggest that integrating electrofocusing with plasmonic sensing offers a pathway to overcome mass transport barriers. They propose that this dual-modality approach provides a scalable solution for high-sensitivity diagnostics in complex clinical samples, contrasting with traditional biosensors that lack active analyte control.
